These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New expanded access drugs for use in combination therapy. Newsline People AIDS Coalit N Y; 1998 Dec; ():22-3. PubMed ID: 11367085 [TBL] [Abstract][Full Text] [Related]
4. Expanded access to experimental drugs: activists seek more open programs. Grinberg L AIDS Treat News; 1997 Nov; (No 282):6-7. PubMed ID: 11364904 [TBL] [Abstract][Full Text] [Related]
8. Glaxo Wellcome's two new drugs. Res Initiat Treat Action; 1998 Dec; 4(7):14. PubMed ID: 11366081 [TBL] [Abstract][Full Text] [Related]
9. The new drugs and how to use them. Gallant JE Hopkins HIV Rep; 1999 Jan; 11(1):2, 7. PubMed ID: 11366160 [TBL] [Abstract][Full Text] [Related]
10. Amprenavir (Agenerase) now available in expanded access. AIDS Treat News; 1998 Oct; (No 304):5. PubMed ID: 11365864 [TBL] [Abstract][Full Text] [Related]
11. The fuss over 1592. Vazquez E Posit Aware; 1997; 8(5):26-7. PubMed ID: 11364637 [TBL] [Abstract][Full Text] [Related]
13. Fifth Conference on Retroviruses & Opportunistic Infections. Interview by Ron Baker. Follansbee S; Deeks S; Bartnoff H Newsline People AIDS Coalit N Y; 1998 Mar; ():7-14. PubMed ID: 11367453 [TBL] [Abstract][Full Text] [Related]
15. Antiretroviral update from the Interscience Conference on Antimicrobial Agents and Chemotherapy. Newsline People AIDS Coalit N Y; 1998 Dec; ():16-8. PubMed ID: 11367083 [TBL] [Abstract][Full Text] [Related]
16. Amprenavir: a new protease inhibitor nears approval. Highleyman L BETA; 1999 Jan; 12(1):8-9. PubMed ID: 11367244 [TBL] [Abstract][Full Text] [Related]